Radioisotope-labeled tyrosine kinase inhibitors in the diagnosis and treatment of lung cancer
Crossref DOI link: https://doi.org/10.1007/s10967-025-10295-9
Published Online: 2025-08-02
Published Print: 2025-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zahid, Muhammad
Wang, Hongliang
Li, Yanyan
Zhang, Jian https://orcid.org/0009-0001-6628-8989
Text and Data Mining valid from 2025-08-01
Version of Record valid from 2025-08-01
Article History
Received: 20 March 2025
Accepted: 18 July 2025
First Online: 2 August 2025
Declarations
:
: The authors have declared that no competing interest exists.